Ligand-protein studies for development of inhibitors of S100P, as a potential novel therapy for pancreatic cancer

Arts & Humanities

1. Cancer 100%
2. Research Collaboration 67%
3. Therapy 66%
4. Hertfordshire 62%
5. Accelerator 58%
6. University of Cambridge 54%
7. Protein 51%